Frank Sands's BSX Position Overview
Frank Sands (via Sands Capital Management, LLC) currently holds 805,164 shares of Boston Scientific Corporation (BSX) worth $76.77 M, representing 0.23% of the portfolio. First purchased in 2019-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Frank Sands has maintained a strategic position in BSX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 805,164 shares. Largest reduction occurred in Q1 2021, reducing 1.62 M shares.
Analysis based on 13F filings available since 2013 Q2
Frank Sands's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Frank Sands
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +805,164 | New Buy | 805,164 | $95.35 |
| Q1 2021 | -1.62 M | Sold Out | 0 | $0.00 |
| Q4 2020 | +59,571 | Add 3.81% | 1.62 M | $35.95 |
| Q3 2020 | -23,713 | Reduce 1.49% | 1.56 M | $38.21 |
| Q2 2020 | +387,743 | Add 32.35% | 1.59 M | $35.11 |
| Q1 2020 | +4,525 | Add 0.38% | 1.2 M | $32.63 |
| Q4 2019 | +394,072 | Add 49.25% | 1.19 M | $45.22 |
| Q3 2019 | +229,560 | Add 40.24% | 800,084 | $40.69 |
| Q2 2019 | +410,331 | Add 256.15% | 570,524 | $42.98 |
| Q1 2019 | +160,193 | New Buy | 160,193 | $38.38 |
Frank Sands's Boston Scientific Corporation Investment FAQs
Frank Sands first purchased Boston Scientific Corporation (BSX) in Q1 2019, acquiring 160,193 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Frank Sands has held Boston Scientific Corporation (BSX) for 10 quarters since Q1 2019.
Frank Sands's largest addition to Boston Scientific Corporation (BSX) was in Q4 2025, adding 805,164 shares worth $76.77 M.
According to the latest 13F filing for Q4 2025, Frank Sands's firm, Sands Capital Management, LLC, owns 805,164 shares of Boston Scientific Corporation (BSX), valued at approximately $76.77 M.
As of the Q4 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.23% of Frank Sands's publicly disclosed stock portfolio, making it one of their key holdings.
Frank Sands's peak holding in Boston Scientific Corporation (BSX) was 1,622,282 shares, as reported at the end of Q4 2020.